Theme: Financing rejuvenation
Topic: TBC
Date/Time: Aug 18 @12:05 PM
Dr. Moody is a process-oriented drug developer and executive who has specialized in the study of aging and aging mechanisms for over a decade. Since 2013, Dr. Moody has successfully built Ichor Life Sciences (formerly Ichor Therapeutics) from a living room start-up into a premier, vertically integrated research organization focused on drug discovery and development for pathways of aging. R&D initiatives that constitute Ichor’s portfolio companies span enzyme therapy, small molecules, antibody mimetics, contract research services and a strategic investment fund. Dr. Moody holds a PhD in biochemistry and molecular biology from University of Miami’s Miller School of Medicine and an MBA in risk management from Concordia University.